121 related articles for article (PubMed ID: 9549375)
1. [Molecular modeling of immunological proteins by bioinformatics].
Nakamura H
Nihon Rinsho; 1998 Mar; 56(3):795-802. PubMed ID: 9549375
[TBL] [Abstract][Full Text] [Related]
2. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
[TBL] [Abstract][Full Text] [Related]
3. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction.
Oliva B; Bates PA; Querol E; Avilés FX; Sternberg MJ
J Mol Biol; 1998 Jun; 279(5):1193-210. PubMed ID: 9642095
[TBL] [Abstract][Full Text] [Related]
4. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue.
Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H
Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282
[TBL] [Abstract][Full Text] [Related]
5. Predicting antibody complementarity determining region structures without classification.
Choi Y; Deane CM
Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
[TBL] [Abstract][Full Text] [Related]
6. Conformational sampling of CDR-H3 in antibodies by multicanonical molecular dynamics simulation.
Shirai H; Nakajima N; Higo J; Kidera A; Nakamura H
J Mol Biol; 1998 May; 278(2):481-96. PubMed ID: 9571065
[TBL] [Abstract][Full Text] [Related]
7. A germline knowledge based computational approach for determining antibody complementarity determining regions.
Zhao S; Lu J
Mol Immunol; 2010 Jan; 47(4):694-700. PubMed ID: 19939452
[TBL] [Abstract][Full Text] [Related]
8. High-resolution modeling of antibody structures by a combination of bioinformatics, expert knowledge, and molecular simulations.
Shirai H; Ikeda K; Yamashita K; Tsuchiya Y; Sarmiento J; Liang S; Morokata T; Mizuguchi K; Higo J; Standley DM; Nakamura H
Proteins; 2014 Aug; 82(8):1624-35. PubMed ID: 24756852
[TBL] [Abstract][Full Text] [Related]
9. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
[TBL] [Abstract][Full Text] [Related]
10. Structural classification of CDR-H3 in antibodies.
Shirai H; Kidera A; Nakamura H
FEBS Lett; 1996 Dec; 399(1-2):1-8. PubMed ID: 8980108
[TBL] [Abstract][Full Text] [Related]
11. Structural classification of CDR-H3 revisited: a lesson in antibody modeling.
Kuroda D; Shirai H; Kobori M; Nakamura H
Proteins; 2008 Nov; 73(3):608-20. PubMed ID: 18473362
[TBL] [Abstract][Full Text] [Related]
12. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
[TBL] [Abstract][Full Text] [Related]
13. Modeling the anti-CEA antibody combining site by homology and conformational search.
Mas MT; Smith KC; Yarmush DL; Aisaka K; Fine RM
Proteins; 1992 Dec; 14(4):483-98. PubMed ID: 1438186
[TBL] [Abstract][Full Text] [Related]
14. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
[TBL] [Abstract][Full Text] [Related]
16. The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model.
Essen LO; Skerra A
J Mol Biol; 1994 Apr; 238(2):226-44. PubMed ID: 8158652
[TBL] [Abstract][Full Text] [Related]
17. Conformational analysis of the first observed non-proline cis-peptide bond occurring within the complementarity determining region (CDR) of an antibody.
Bates PA; Dokurno P; Freemont PS; Sternberg MJ
J Mol Biol; 1998 Dec; 284(3):549-55. PubMed ID: 9826497
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
Paula S; Monson N; Ball WJ
Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
[TBL] [Abstract][Full Text] [Related]
19. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides.
Knappik A; Ge L; Honegger A; Pack P; Fischer M; Wellnhofer G; Hoess A; Wölle J; Plückthun A; Virnekäs B
J Mol Biol; 2000 Feb; 296(1):57-86. PubMed ID: 10656818
[TBL] [Abstract][Full Text] [Related]
20. Predicting antibody hypervariable loop conformations. II: Minimization and molecular dynamics studies of MCPC603 from many randomly generated loop conformations.
Fine RM; Wang H; Shenkin PS; Yarmush DL; Levinthal C
Proteins; 1986 Dec; 1(4):342-62. PubMed ID: 3449860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
